Phase 2 Trial of Rosuvastatin (Crestor®) Combined With Standard Chemoradiation Therapy in the Treatment of High-Risk Locally Advanced Rectal Cancer
This study will evaluate whether the addition of Rosuvastatin to standard chemoradiation
therapy for the treatment of locally advanced rectal cancer may improve the pathological
response rate and survival compared to standard chemoradiation therapy alone.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society